2Zheng Y, Stein R, Kwan T, et al. Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China. Clin Cardiol,2009,32(9):491-497. 被引量：1
3Yang G,Kong L,Zhao W, et al. Emergence of chronic non- communicable diseases in China. Lancet, 2008, 372 (9650) : 1697-1705. 被引量：1
4Wang Y, Mi J, Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes, 2007,31 ( 1 ) : 177-188. 被引量：1
5World Health Organization. Preventing chronic diseases:a vital investment. Geneva: World Health Organization, 2005. 被引量：1
6Chen J, Peto R, Pan W, et al. Mortality, biochemistry, diet and lifestyle in rural China:geographic study of the characteristic of 69 counties in China's Mainland and 16 areas in Taiwan. Oxford: Oxford University Press, 2006. 被引量：1
7World Health Organization. A prioritized research agenda for prevention and control of noncommunicable diseases. Geneva: World Health Organization, 2011. 被引量：1
8Chen Z, Lee L, Chen J, et al of Chronic Disease in China 34:1243-1249. 被引量：1
9Cohort profile: the Kadoorie Study (KSCDC). Int J Epidemiol, 2005, Kessler RC, Andrews G,Mroczek D,et al. The World Health Organization Composite International Diagnostic Interview short-form (CIDI-SF). Int J Meth Psychiat Res, 1998, 7 (4) : 171-185. 被引量：1
10Clarke R, Lewington S, Donald A, et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk, 2001, 8 (6) :363-369. 被引量：1
10Jee K,Kim GH.Potentiality of big data in the medical sector:focus on how to reshape the healthcare system [J].Healthc Inform Res,2013,19(2):79-85. 被引量：1
